Abstract:AIM: To investigate the synergic effect of survivin antisense oligonucleotide (ASODN) combined with bcl-2 ASODN on apoptosis in lung cancer cell lines, and probe into its anti-cancer effect. METHODS ① The experiment was carried out in the immunological laboratory of Bengbu Medical College between August 2002 and April 2003. The NCI-H446 cells at logarithmic phase were divided into 6 groups: blank control group, liposomes 10 mg/L group (only blank liposomes was added), NSODN 500 nmol/L group (the first 3 groups were the control groups), survivin ASODN 500 nmol/L group, bcl-2 ASODN 5 μmol/L group, survivin ASODN 500 nmol/L +bcl-2 ASODN 5 μmol/L group (different oligonucleotides were transfected under mediation of liposomes, and then the cells were collected for the following tests). ② Under medium of liposomes, the lung cancer cell lines, NCI-H446 and SPC-A1 were transferred with survivin ASODN, and the survivin mRNA expression was detected with reverse transcription-polymerase chain reaction (RT-PCR) at 72 hours. Apoptosis index=(resting phase/DNA G1 phase)/whole cell cycle ×100%. Proliferation index=(DNA synthesis phase+G2 phase/M phase/whole cell cycle ×100%. ③ After NCI-H446 cell was treated with survivin ASODN alone or combined with bcl-2 ASODN, the cell growth inhibitory rate of NCI-H446 cell was detected with methyl-thiazol-tetrazolium (MTT) assay, and the interaction index of the two drugs was calculated, and the cell death rate was detected with trypan blue staining. ④ The analysis of variance and q test were applied in comaparing the difference of measurement data. RESULTS: ① The surviving gene expression was observed in both lung cancer cell lines. After cell line was treated with survivin ASODN, the growth inhibition and apoptosis occurred, and the survivin mRNA was obviously down-regulated, and the survivin mRNA inhibitory rates of NCI-H446 and SPC-A1 cells after treated with ASODN for 72 hours were 62.72% and 67.43% respectively. ② The results of MTT assay showed that both survivin ASODN and bcl-2 ASODN alone had the effect of growth suppression on NCI-H446 cells. The cell growth inhibitory rate of survivin ASODN combined with bcl-2 ASODN was 64.9%, was superior to that of alone application (bcl-2 ASODN alone was 34.2%) (P < 0.01), and the interaction index of the two drugs was 0.708. The trypan blue staining showed that the cell death rate in the survivin ASODN 500 nmol/L + bcl-2 ASODN 5 μmol/L group was 62.1%, which was higher than those of alone application (31.4% and 41.4%). The flow cytometer indicated that both survivin ASODN and bcl-2 ASODN could induce apoptosis as compared with the control groups, the apoptosis rates were 43.6% and 30.7% respectively, and it increased to 58.6% in the survivin ASODN 500 nmol/L + bcl-2 ASODN 5 μmol/L group (P < 0.01). CONCLUSION: ① Survivin ASODN can inhibit the lung cancer cell lines survivin gene expression, and induce apoptosis and growth suppression. ② Survivin ASODN combined with bcl-2 ASODN have a significant synergic anti-cancer role

Expression of survivin and vascular endothelial growth factor and their relationship in bladder cancer and ASODN targeting survivin inducing apoptosis of bladder cancer cell line in vitro

Expression of Survivin and Its Correlation with Expression of Bcl-2 and P53 in Colorectal Adenocarcinoma

Effects of Autocrine Vascular Endothelial Growth Factor (VEGF) in Non-Small Cell Lung Cancer Cell Line A549.

Studies on Antisense Oligodeoxynucleotide Targeting Survivin Inducing Apoptosis of Human Bladder Transitional Cell Carcinoma T24 Cell Lines

[Effects of Vascular Endothelial Growth Factor (VEGF) Antisense Oligodeoxynucleotide on Mrna and Expression of VEGF, Flt-1, and Kinase Insert Domain Containing Receptor and VEGF Excretion in Human Gallbladder Carcinoma Cells].

Relationship of VEGF,PCNA,Survivin and pathological grading,clinical stage of bladder cancer

Expression of Apoptosis Inhibitor Gene Survivin in Bladder Carcinoma and Its Clinical Implication

Inhibitory Effect of Recombinant TGF alpha-PE40 Combined with survivin Antisense Oligonucleotides on Bladder Transitional Cell Carcinoma Cells

Antisense Oligonucleotide Targeting Survivin Induces Apoptosis of SMMC-7721 Cell and Enhances Its Sensitivity to Chemotherapeutic Agents in Vitro

Expression of Survivin in Endometrial Cancer and Its Role in Regulating Apoptosis of Endometrial Cancer Cells

Effects of Survivin Small Interfering RNA on Biological Behaviors of Bladder Cancer T24 Cells

Expressions of survivin and the splice variants survivin-2B and survivin-ΔEx3 in bladder cancer and their clinical significance

Expression of Survivin and Its Correlation with VEGF in Non-small Cell Lung Cancer

Expression of Survivin in Bladder Transitional Cell Carcinoma and Its Relationship with Expression of Fas/FasL

Expression of survivin and bcl-2 and their correlation in transitional cell carcinoma of the bladder

Inhibitory effects of antisense oligodexynucleotide on the expression of survivin mRNA and protein in human malignant melanoma cell line A375

Correlation Between the Expression of Survivin and VEGF in BTCC and the Clinical Significance

Antisense oligonucleotide targeting survivin induces apoptosis of renal clear-cell carcinoma cells and enhances their sensitivity to epirubicin in vitro]

The synergic effect of survivin antisense oligonucleotide on apoptosis in lung cancer cell lines

Apoptosis of lung cancer cell lines induced by apoptosis inhibiting gene survivin antisense oligonucleotide combined with bcl-2 antisense oligonucleotide

Expression of survivin and its relationship with vascular endothelial cell growth factor in osteosarcoma